JP2022529500A5 - - Google Patents

Info

Publication number
JP2022529500A5
JP2022529500A5 JP2021562980A JP2021562980A JP2022529500A5 JP 2022529500 A5 JP2022529500 A5 JP 2022529500A5 JP 2021562980 A JP2021562980 A JP 2021562980A JP 2021562980 A JP2021562980 A JP 2021562980A JP 2022529500 A5 JP2022529500 A5 JP 2022529500A5
Authority
JP
Japan
Prior art keywords
fusion protein
nucleic acid
seq
acid construct
recombinant virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562980A
Other languages
English (en)
Japanese (ja)
Other versions
JP7618581B2 (ja
JP2022529500A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029590 external-priority patent/WO2020219726A1/en
Publication of JP2022529500A publication Critical patent/JP2022529500A/ja
Publication of JP2022529500A5 publication Critical patent/JP2022529500A5/ja
Priority to JP2025002919A priority Critical patent/JP7888768B2/ja
Application granted granted Critical
Publication of JP7618581B2 publication Critical patent/JP7618581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562980A 2019-04-23 2020-04-23 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用 Active JP7618581B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025002919A JP7888768B2 (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962837523P 2019-04-23 2019-04-23
US62/837,523 2019-04-23
US202062964844P 2020-01-23 2020-01-23
US62/964,844 2020-01-23
PCT/US2020/029590 WO2020219726A1 (en) 2019-04-23 2020-04-23 Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025002919A Division JP7888768B2 (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Publications (3)

Publication Number Publication Date
JP2022529500A JP2022529500A (ja) 2022-06-22
JP2022529500A5 true JP2022529500A5 (cg-RX-API-DMAC7.html) 2023-04-28
JP7618581B2 JP7618581B2 (ja) 2025-01-21

Family

ID=70680681

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021562980A Active JP7618581B2 (ja) 2019-04-23 2020-04-23 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用
JP2025002919A Active JP7888768B2 (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025002919A Active JP7888768B2 (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Country Status (16)

Country Link
US (3) US12139517B2 (cg-RX-API-DMAC7.html)
EP (1) EP3958871A1 (cg-RX-API-DMAC7.html)
JP (2) JP7618581B2 (cg-RX-API-DMAC7.html)
KR (2) KR102981881B1 (cg-RX-API-DMAC7.html)
CN (2) CN120960394A (cg-RX-API-DMAC7.html)
AU (2) AU2020262281B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020868A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137368A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021015653A2 (cg-RX-API-DMAC7.html)
IL (1) IL287384A (cg-RX-API-DMAC7.html)
MX (1) MX2021012836A (cg-RX-API-DMAC7.html)
PE (1) PE20212332A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552554A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202111443SA (cg-RX-API-DMAC7.html)
TW (1) TWI862584B (cg-RX-API-DMAC7.html)
WO (1) WO2020219726A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020131632A1 (en) 2018-12-20 2020-06-25 Regeneron Pharmaceuticals, Inc. Nuclease-mediated repeat expansion
JP7618581B2 (ja) * 2019-04-23 2025-01-21 サンガモ セラピューティクス, インコーポレイテッド 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用
GB202010075D0 (en) * 2020-07-01 2020-08-12 Imp College Innovations Ltd Therapeutic nucleic acids, peptides and uses
IL311610A (en) 2021-09-21 2024-05-01 Scribe Therapeutics Inc Engineered CASX suppressor systems

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420032A (en) 1991-12-23 1995-05-30 Universitge Laval Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
US5792632A (en) 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
JP4012243B2 (ja) 1994-01-18 2007-11-21 ザ スクリップス リサーチ インスティチュート 亜鉛フィンガータンパク質誘導体およびそのための方法
CA2186118C (en) 1994-03-23 2010-10-19 Richard W. Hanson Compacted nucleic acids and their delivery to cells
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
CA2196419C (en) 1994-08-20 2007-08-21 Yen Choo Improvements in or relating to binding proteins for recognition of dna
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
CA2329259C (en) 1998-05-27 2003-08-05 Avigen, Inc. Convection-enhanced delivery of aav vectors
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6503717B2 (en) 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
AU7866400A (en) 1999-10-07 2001-05-10 Baylor College Of Medicine Novel zinc finger protein
AU2001250774B2 (en) 2000-02-08 2005-01-27 Sangamo Biosciences, Inc. Cells expressing zinc finger proteins for drug discovery
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
ATE360361T1 (de) 2000-09-28 2007-05-15 Sangamo Biosciences Inc Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen
US20050235369A1 (en) * 2001-03-28 2005-10-20 Yen Choo Gene regulation II
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US7182944B2 (en) 2001-04-25 2007-02-27 The United States Of America As Represented By The Department Of Health And Human Services Methods of increasing distribution of nucleic acids
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
EP1463805B1 (en) 2001-12-17 2014-10-22 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
US7074596B2 (en) 2002-03-25 2006-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse mRNA cap analogues
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
CN1897977A (zh) 2003-10-20 2007-01-17 Ns基因公司 帕金森氏病的体内基因治疗
WO2006042090A1 (en) 2004-10-05 2006-04-20 Avigen, Inc. Stepped cannula
WO2006121866A2 (en) 2005-05-05 2006-11-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
JP5238503B2 (ja) 2005-08-23 2013-07-17 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 対流増加送達を用いた治療薬の慢性的な送達のための逆流防止カニューレ及びシステム
DK3246403T3 (da) 2005-10-18 2020-10-26 Prec Biosciences Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet
SI2019683T2 (sl) 2006-04-25 2022-10-28 The Regents Of The University Of California Dajanje rastnih faktorjev za zdravljenje motenj CŽS
EP2027262B1 (en) 2006-05-25 2010-03-31 Sangamo Biosciences Inc. Variant foki cleavage half-domains
US7837668B2 (en) 2006-10-10 2010-11-23 Ceregene, Inc. Needle assembly for use in delivering precise dosages of proteinaceous pharmaceutical compositions and methods for use of same
US8153773B2 (en) 2007-06-19 2012-04-10 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
JP5763341B2 (ja) 2007-09-27 2015-08-12 サンガモ バイオサイエンシーズ, インコーポレイテッド 生物学的活性のあるヌクレアーゼの迅速なインビボ同定法
AU2009212247A1 (en) 2008-02-08 2009-08-13 Sangamo Therapeutics, Inc. Treatment of chronic pain with zinc finger proteins
JP5763530B2 (ja) 2008-06-10 2015-08-12 サンガモ バイオサイエンシーズ, インコーポレイテッド Bax−およびBak−欠損細胞株の生成のための方法および組成物
JP5908725B2 (ja) 2008-08-22 2016-04-26 サンガモ バイオサイエンシーズ, インコーポレイテッド 標的一本鎖開裂および標的組込みのための方法、並びに組成物
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
CA2769262C (en) 2009-07-28 2019-04-30 Sangamo Biosciences, Inc. Methods and compositions for treating trinucleotide repeat disorders
EA022786B1 (ru) 2009-07-31 2016-03-31 Этрис Гмбх Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
JP6137596B2 (ja) 2010-02-08 2017-05-31 サンガモ セラピューティクス, インコーポレイテッド 遺伝子操作された切断ハーフドメイン
EP2566972B1 (en) 2010-05-03 2020-01-15 Sangamo Therapeutics, Inc. Compositions for linking zinc finger modules
AU2011256838B2 (en) 2010-05-17 2014-10-09 Sangamo Therapeutics, Inc. Novel DNA-binding proteins and uses thereof
WO2013074999A1 (en) 2011-11-16 2013-05-23 Sangamo Biosciences, Inc. Modified dna-binding proteins and uses thereof
CA2865011C (en) * 2012-02-29 2021-06-15 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
WO2014134351A2 (en) 2013-02-27 2014-09-04 The Broad Institute, Inc. T cell balance gene expression, compositions of matters and methods of use thereof
EP2997146A4 (en) 2013-05-15 2017-04-26 Sangamo BioSciences, Inc. Methods and compositions for treatment of a genetic condition
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
MX391904B (es) 2013-11-11 2025-03-12 Sangamo Biosciences Inc Un represor genetico para usarse en el tratamiento de la enfermedad de huntington.
KR20160097338A (ko) 2013-12-12 2016-08-17 더 브로드 인스티튜트, 인코퍼레이티드 뉴클레오티드 반복 장애에서의 crispr-cas 시스템의 조성물 및 방법 및 용도
EP3929279A1 (en) 2014-03-18 2021-12-29 Sangamo Therapeutics, Inc. Methods and compositions for regulation of zinc finger protein expression
WO2015153760A2 (en) 2014-04-01 2015-10-08 Sangamo Biosciences, Inc. Methods and compositions for prevention or treatment of a nervous system disorder
BR112016025849A2 (pt) 2014-05-08 2017-10-17 Chdi Foundation Inc métodos e composições para o tratamento da doença de huntington
US9970001B2 (en) * 2014-06-05 2018-05-15 Sangamo Therapeutics, Inc. Methods and compositions for nuclease design
GB201418965D0 (cg-RX-API-DMAC7.html) 2014-10-24 2014-12-10 Ospedale San Raffaele And Fond Telethon
CA3035810A1 (en) 2015-09-02 2017-03-09 University Of Massachusetts Detection of gene loci with crispr arrayed repeats and/or polychromatic single guide ribonucleic acids
AU2016359629B2 (en) 2015-11-23 2023-03-09 Ranjan BATRA Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/Cas9
CA3009308A1 (en) * 2015-12-23 2017-06-29 Chad Albert COWAN Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration
WO2018002762A1 (en) * 2016-06-29 2018-01-04 Crispr Therapeutics Ag Materials and methods for treatment of amyotrophic lateral sclerosis (als) and other related disorders
MA46018A (fr) 2016-08-19 2019-06-26 Bluebird Bio Inc Activateurs d'édition du génome
IL264792B2 (en) 2016-08-24 2023-10-01 Sangamo Therapeutics Inc Engineered target-specific zinc-finger nucleases
WO2018039471A2 (en) 2016-08-25 2018-03-01 Trustees Of Boston University Synthetic transcriptional and epigenetic regulators based on engineered, orthogonal zinc finger proteins
CN110214184B (zh) 2016-12-01 2024-07-02 桑格摩生物治疗股份有限公司 τ蛋白调节剂以及用于其递送的方法和组合物
AU2018264996A1 (en) * 2017-05-09 2019-12-05 University Of Massachusetts Methods of treating Amyotrophic Lateral Sclerosis (ALS)
EP3716767A4 (en) 2017-10-24 2021-11-24 Sangamo Therapeutics, Inc. METHODS AND COMPOSITIONS FOR TREATMENT OF RARE DISEASES
JP7618581B2 (ja) * 2019-04-23 2025-01-21 サンガモ セラピューティクス, インコーポレイテッド 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Similar Documents

Publication Publication Date Title
CN106459932B (zh) 高胆红素血症的治疗
CA2985372C (en) Polynucleotides, vectors and methods for insertion and expression of transgenes
JP7616995B2 (ja) 神経変性疾患のための遺伝子治療
CN120324641A (zh) 用于治疗达农病的基因治疗载体
CN113710693B (zh) Dna结合结构域反式激活因子及其用途
CA2369985A1 (en) Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
CN104936606A (zh) 糖原贮积病的基因疗法
JP2025521102A5 (cg-RX-API-DMAC7.html)
WO2020039425A1 (en) Vectors expressing klotho for treating cancer
CA2859920A1 (en) Variants of yeast ndi1 gene, and uses thereof in the treatment of disease associated with mitochondrial dysfunction
JP2022521432A5 (cg-RX-API-DMAC7.html)
SG11202111443SA (en) Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof
JP2023542241A5 (cg-RX-API-DMAC7.html)
EP4185303A1 (en) Dna-binding domain transactivators and uses thereof
TW202426033A (zh) Bag3用於治療心臟澱粉樣變性之方法及用途
EP4518882A1 (en) Bag3 and protein quality control in the brain
CN117916365B (zh) 用于治疗结晶样视网膜变性的重组腺相关病毒载体
KR20230112672A (ko) 신경변성 질환을 위한 유전자 요법
RU2021133872A (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения
CN115996758A (zh) 使sgcg在肌肉和心脏中充分表达的基因治疗表达系统
EP4089171A1 (en) Recombinant tert-encoding viral genomes and vectors
CA3218631A1 (en) Vector system
JP2023549620A (ja) 組換え補体タンパク質を産生させる方法、そのベクターおよび治療的使用
RU2024129746A (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения
JP2023545972A (ja) アルファ-シヌクレイン発現を抑制するための新規ジンクフィンガータンパク質転写因子